Partial parasite clearance with AF is not an invalidation of S
M.BaranM.GamboneC.RileyS.et al (2016)
Recent research has also suggested that GLP-1s might have a direct effect on the hypothalamic-pituitary-thyroid axis, potentially lowering TSH (Thyroid Stimulating Hormone) levels independently of weight loss
While we understand that off-label prescribing can be beneficial in some circumstances, we cannot support it when it is directly contributing to ongoing shortages for those people living with type 2 diabetes and the impact this has on managing it well
Other challenges There are several other challenges inherent to GLP-1 drugs, including: Cost and accessibility: The high cost of many GLP-1 agonists remains a significant barrier for many patients, with some insurance plans not covering these medications, particularly for obesity management
Boosts melanin Raises the enzyme responsible for producing skin-darkening pigment